Siemens Nuclear Medicine Group Leads Worldwide Market Second Year in a Row.

Business Editors, Health/Medical Writers

HOFFMAN ESTATES, Ill.--(BUSINESS WIRE)--Oct. 20, 2000

For the second year in a row, Siemens Medical Systems, Inc., Nuclear Medicine Group, held the number one worldwide market position in nuclear medicine with a combined SPECT and PET market share in the mid-thirty percentile, as announced by Barbara Franciose, president, Siemens Nuclear Medicine Group.

The company reported an early 30% market share in 1999, enjoying clear growth in both segments.

Franciose attributed the past fiscal year sales to "significant growth in both the positron emission tomography (PET) category and in general nuclear medicine products, and to cross-modality synergies in oncology and cardiology with our new computer platform."

According to Randy Weatherhead, vice president of sales and marketing, Siemens Nuclear Medicine Group, "Our growth in the past year was fueled by Siemens' capability to meet the expanding demand for nuclear products, worldwide, by offering the widest array of SPECT and PET products available."

Weatherhead reported particularly strong demand for Siemens' products in three areas -- the company's e.cam(R) gamma camera line, its e.soft(TM) computer technology, and ECAT(R) scanners.

"With the introduction this past June of our new e.cam duet(TM), our e.cam product line now consists of seven models offering optimized imaging capabilities for any clinical requirement," Weatherhead said. "We fully expect that the e.cam duet, which is the first camera of its kind specifically designed for SPECT and high-energy FDG imaging, will give our camera line sales added momentum during the next fiscal year." Other models in the Siemens e.cam line include the e.cam Standard Single; e.cam Single; e.cam Fixed 180(Degree); e.cam Variable-Angle; e.cam+ NaI Coincidence, and the e.cam Cardiac.

Siemens e.soft nuclear medicine workstations with syngo, the company's new common medical imaging software platform, allows users to seamlessly access and view multimodality computed tomography (CT), magnetic resonance (MR), ultrasound, angiography, and other DICOM image and patient data on any Siemens syngo-based computer.

Also contributing to Siemens' number one worldwide market share, said Weatherhead, was the company's line of technologically innovative ECAT scanners that produce leading edge PET imaging. Included in that line are the ECAT(R) ART(TM), the first low-cost BGO PET scanner for all clinical applications; ECAT(R) EXACT(TM), the most widely used PET scanner in the world; and ECAT EXACT HR+, the highest performance PET scanner available.

"By remaining in the leading position worldwide, it is clear we are living our vision to provide our customers the best clinical value, functionality and patient-handling needed to manage their patients," said Franciose. "During the coming fiscal year, we expect to increase our share of the market through additional cardiology and oncology cross-modality solutions.

"Siemens will remain committed to setting new industry standards and to providing the highest-quality healthcare solutions possible."

The Nuclear Medicine Group, based in Hoffman Estates, IL, develops and markets a wide range of nuclear medicine products. The Group, currently the market share leader, provides integrated nuclear imaging technology solutions to the oncology, cardiology, and neurology markets and has produced such innovative technologies as its market-leading e.cam(R) gamma camera, and e.soft(TM), the Group's Nu.LOGIC(TM) workflow-based image acquisition and processing workstation (jointly developed by Siemens and Toshiba). Additional information can be obtained through the company's web site: www.sms.siemens.com/nmg. The company is part of Siemens Medical Engineering Group, Erlangen, Germany, one of the largest suppliers of healthcare services in the world.

Press releases issued are available on our web site at: http://www.usa.siemens.com/News_and_Press/RecentPressReleases.htm